Zhejiang Runyang New Material Technology Past Earnings Performance
Past criteria checks 4/6
Zhejiang Runyang New Material Technology's earnings have been declining at an average annual rate of -39.1%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been declining at an average rate of 14.8% per year. Zhejiang Runyang New Material Technology's return on equity is 4.6%, and it has net margins of 15%.
Key information
-39.1%
Earnings growth rate
-47.4%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | -14.8% |
Return on equity | 4.6% |
Net Margin | 15.0% |
Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Zhejiang Runyang New Material Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 389 | 59 | 42 | 10 |
31 Dec 23 | 359 | 42 | 40 | 11 |
30 Sep 23 | 324 | 32 | 41 | 15 |
30 Jun 23 | 299 | 16 | 39 | 16 |
31 Mar 23 | 336 | 13 | 41 | 19 |
31 Dec 22 | 390 | 33 | 43 | 22 |
30 Sep 22 | 443 | 36 | 48 | 27 |
30 Jun 22 | 508 | 65 | 53 | 28 |
31 Mar 22 | 514 | 81 | 47 | 27 |
01 Jan 22 | 502 | 90 | 44 | 23 |
30 Sep 21 | 496 | 107 | 36 | 19 |
30 Jun 21 | 486 | 121 | 31 | 18 |
31 Mar 21 | 465 | 127 | 34 | 17 |
31 Dec 20 | 434 | 127 | 30 | 16 |
30 Sep 20 | 403 | 124 | 57 | 23 |
31 Dec 19 | 365 | 116 | 32 | 12 |
31 Dec 18 | 325 | 87 | 23 | 10 |
31 Dec 17 | 168 | 21 | 34 | 8 |
30 Jun 17 | 99 | 16 | 11 | 0 |
31 Mar 17 | 77 | 11 | 10 | 0 |
31 Dec 16 | 56 | 6 | 10 | 0 |
30 Sep 16 | 47 | 5 | 9 | 0 |
30 Jun 16 | 39 | 3 | 9 | 0 |
31 Mar 16 | 35 | 2 | 8 | 0 |
31 Dec 15 | 31 | 2 | 7 | 0 |
31 Dec 14 | 22 | 0 | 4 | 0 |
31 Dec 13 | 16 | 0 | 3 | 0 |
Quality Earnings: 300920 has high quality earnings.
Growing Profit Margin: 300920's current net profit margins (15%) are higher than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300920's earnings have declined by 39.1% per year over the past 5 years.
Accelerating Growth: 300920's earnings growth over the past year (347.6%) exceeds its 5-year average (-39.1% per year).
Earnings vs Industry: 300920 earnings growth over the past year (347.6%) exceeded the Chemicals industry -19.8%.
Return on Equity
High ROE: 300920's Return on Equity (4.6%) is considered low.